JHIU
AGN

Janus Henderson Investors US’s Allergan Inc AGN Stock Holding History

Janus Henderson Investors US’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,294,842
Closed -$275M – 1165
2014
Q4 		$275M Buy
1,294,842
+13,942
+1% +$2.77M 0.24% 109
2014
Q3 		$228M Buy
1,280,900
+220,361
+21% +$36.6M 0.21% 130
2014
Q2 		$179M Sell
1,060,539
-429,820
-29% -$66.9M 0.16% 172
2014
Q1 		$185M Sell
1,490,359
-557,748
-27% -$67.9M 0.17% 159
2013
Q4 		$228M Sell
2,048,107
-246,770
-11% -$23.6M 0.21% 123
2013
Q3 		$208M Buy
2,294,877
+375,430
+20% +$33.7M 0.21% 135
2013
Q2 		$162M Buy
+1,919,447
New +$199M 0.17% 156

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $5B AUM 26.58% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 10.02% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

Janus Henderson Investors US's AGN Position: Q1 2015 in Review

Janus Henderson Investors US sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 1,294,842 shares — an estimated $275M sold.

Janus Henderson Investors US first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $275M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Janus Henderson Investors US reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Janus Henderson Investors US sold 1,294,842 Allergan Inc shares in Q1 2015, an estimated $275M.
  • Janus Henderson Investors US first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Janus Henderson Investors US's Allergan Inc position peaked at $275M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Janus Henderson Investors US's 13F filing for Q1 2015, filed 15 May 2015.